BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23165940)

  • 1. Core2 O-glycan-expressing prostate cancer cells are resistant to NK cell immunity.
    Okamoto T; Yoneyama MS; Hatakeyama S; Mori K; Yamamoto H; Koie T; Saitoh H; Yamaya K; Funyu T; Fukuda M; Ohyama C; Tsuboi S
    Mol Med Rep; 2013 Feb; 7(2):359-64. PubMed ID: 23165940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MUC1 carrying core 2 O-glycans functions as a molecular shield against NK cell attack, promoting bladder tumor metastasis.
    Suzuki Y; Sutoh M; Hatakeyama S; Mori K; Yamamoto H; Koie T; Saitoh H; Yamaya K; Funyu T; Habuchi T; Arai Y; Fukuda M; Ohyama C; Tsuboi S
    Int J Oncol; 2012 Jun; 40(6):1831-8. PubMed ID: 22446589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans.
    Tsuboi S; Sutoh M; Hatakeyama S; Hiraoka N; Habuchi T; Horikawa Y; Hashimoto Y; Yoneyama T; Mori K; Koie T; Nakamura T; Saitoh H; Yamaya K; Funyu T; Fukuda M; Ohyama C
    EMBO J; 2011 Jun; 30(15):3173-85. PubMed ID: 21712812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Core 2 β1,6-N-acetylglucosaminyltransferases accelerate the escape of choriocarcinoma from natural killer cell immunity.
    Nakamura K; Niimi K; Yamamoto E; Ikeda Y; Nishino K; Suzuki S; Kajiyama H; Kikkawa F
    Biochem Biophys Rep; 2021 Jul; 26():100951. PubMed ID: 33644424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mechanism for evasion of CTL immunity by altered O-glycosylation of HLA class I.
    Sutoh Yoneyama M; Tobisawa Y; Hatakeyama S; Sato M; Tone K; Tatara Y; Kakizaki I; Funyu T; Fukuda M; Hoshi S; Ohyama C; Tsuboi S
    J Biochem; 2017 Jun; 161(6):479-492. PubMed ID: 28011817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-glycans of core2 beta(1,6)-N-acetylglucosaminyltransferase-I (C2GnT-I) but not those of alpha(1,3)-fucosyltransferase-VII (FucT-VII) are required for the synthesis of functional P-selectin glycoprotein ligand-1 (PSGL-1): effects on P-, L- and E-selectin binding.
    Prorok-Hamon M; Notel F; Mathieu S; Langlet C; Fukuda M; El-Battari A
    Biochem J; 2005 Nov; 391(Pt 3):491-502. PubMed ID: 15926890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Core2 O-glycan structure is essential for the cell surface expression of sucrase isomaltase and dipeptidyl peptidase-IV during intestinal cell differentiation.
    Lee SH; Yu SY; Nakayama J; Khoo KH; Stone EL; Fukuda MN; Marth JD; Fukuda M
    J Biol Chem; 2010 Nov; 285(48):37683-92. PubMed ID: 20841351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor defense systems using O-glycans.
    Tsuboi S
    Biol Pharm Bull; 2012; 35(10):1633-6. PubMed ID: 23037152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of core 2 beta-1,6-N-acetylglucosaminyltransferase in a human pancreatic cancer cell line results in altered expression of MUC1 tumor-associated epitopes.
    Beum PV; Singh J; Burdick M; Hollingsworth MA; Cheng PW
    J Biol Chem; 1999 Aug; 274(35):24641-8. PubMed ID: 10455130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of a differentiation antigen and poly-N-acetyllactosaminyl O-glycans directed by a cloned core 2 beta-1,6-N-acetylglucosaminyltransferase.
    Bierhuizen MF; Maemura K; Fukuda M
    J Biol Chem; 1994 Feb; 269(6):4473-9. PubMed ID: 8308016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of compact Golgi morphology in advanced prostate cancer enhances susceptibility to galectin-1-induced apoptosis by modifying mucin O-glycan synthesis.
    Petrosyan A; Holzapfel MS; Muirhead DE; Cheng PW
    Mol Cancer Res; 2014 Dec; 12(12):1704-16. PubMed ID: 25086069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visualizing intracellular distribution and activity of core2 beta(1,6)N-acetylglucosaminyltransferase-I in living cells.
    Prorok-Hamon M; Mathieu S; El-Battari A
    Methods Mol Biol; 2006; 347():171-86. PubMed ID: 17072011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered Golgi localization of core 2 beta-1,6-N-acetylglucosaminyltransferase leads to decreased synthesis of branched O-glycans.
    Skrincosky D; Kain R; El-Battari A; Exner M; Kerjaschki D; Fukuda M
    J Biol Chem; 1997 Sep; 272(36):22695-702. PubMed ID: 9278427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Core 3 mucin-type O-glycan restoration in colorectal cancer cells promotes MUC1/p53/miR-200c-dependent epithelial identity.
    Ye J; Wei X; Shang Y; Pan Q; Yang M; Tian Y; He Y; Peng Z; Chen L; Chen W; Wang R
    Oncogene; 2017 Nov; 36(46):6391-6407. PubMed ID: 28745318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of poly-N-acetyllactosamine in core 2 branched O-glycans. The requirement of novel beta-1,4-galactosyltransferase IV and beta-1,3-n-acetylglucosaminyltransferase.
    Ujita M; McAuliffe J; Schwientek T; Almeida R; Hindsgaul O; Clausen H; Fukuda M
    J Biol Chem; 1998 Dec; 273(52):34843-9. PubMed ID: 9857011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoma-associated expression of core 2 beta-1,6-N-acetylglucosaminyltransferase gene in human colorectal cancer: role of O-glycans in tumor progression.
    Shimodaira K; Nakayama J; Nakamura N; Hasebe O; Katsuyama T; Fukuda M
    Cancer Res; 1997 Dec; 57(23):5201-6. PubMed ID: 9393734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Core3 O-glycan synthase suppresses tumor formation and metastasis of prostate carcinoma PC3 and LNCaP cells through down-regulation of alpha2beta1 integrin complex.
    Lee SH; Hatakeyama S; Yu SY; Bao X; Ohyama C; Khoo KH; Fukuda MN; Fukuda M
    J Biol Chem; 2009 Jun; 284(25):17157-17169. PubMed ID: 19395705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning and expression of a novel beta-1, 6-N-acetylglucosaminyltransferase that forms core 2, core 4, and I branches.
    Yeh JC; Ong E; Fukuda M
    J Biol Chem; 1999 Jan; 274(5):3215-21. PubMed ID: 9915862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-glycosylation of MUC1 mucin in prostate cancer and the effects of its expression on tumor growth in a prostate cancer xenograft model.
    Premaratne P; Welén K; Damber JE; Hansson GC; Bäckström M
    Tumour Biol; 2011 Feb; 32(1):203-13. PubMed ID: 20872286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two opposing roles of O-glycans in tumor metastasis.
    Tsuboi S; Hatakeyama S; Ohyama C; Fukuda M
    Trends Mol Med; 2012 Apr; 18(4):224-32. PubMed ID: 22425488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.